Free alerts

CABA insider buying

Every open-market purchase of Cabaletta Bio, Inc. (CABA) stock by its officers, directors and major shareholders, from SEC Form 4 filings.

Bought, last 12 months$286.21K
Insiders buying (12m)7
Purchases on record7
Last purchase filedJan 21, 2026

In the last 12 months, 7 insiders of Cabaletta Bio, Inc. bought $286.21K of CABA stock on the open market in 7 reported purchases. The most recent was filed on Jan 21, 2026: Chang David J. (Chief Medical Officer) bought 8,800 shares at $2.26, worth $19.89K. The largest purchase on record here is $100.80K by Nichtberger Steven on Jan 21, 2026.

Get the next CABA insider buy on TelegramFree daily recap of the biggest insider purchases, straight from SEC filings. Real-time alerts for Premium members.

Join free on Telegram

All CABA insider purchases

FiledInsiderValueSharesPriceStakeTrade
Jan 21Chang David J.Chief Medical Officer$19.89K8,800$2.26newJan 21SEC
Jan 21Binder GwendolynPresident, Science & Tech.$24.77K11,312$2.19+57%Jan 21SEC
Jan 21Tomasello ShawnDirector$50.22K22,725$2.21newJan 21SEC
Jan 21Gavel SteveChief Commercial Officer$50.33K22,170$2.27newJan 21SEC
Jan 21Nichtberger StevenPresident & CEO, Director$100.80K45,000$2.24+5%Jan 21SEC
Jan 21Simon MarkDirector$25.22K11,061$2.28+8%Jan 21SEC
Jan 21Gerard MichaelGeneral Counsel$14.98K6,600$2.27newJan 21SEC